rs2233152

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The ENST00000600729.2(MIA-RAB4B):​n.-6-426G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.12 in 172,864 control chromosomes in the GnomAD database, including 1,445 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.12 ( 1252 hom., cov: 32)
Exomes 𝑓: 0.12 ( 193 hom. )

Consequence

MIA-RAB4B
ENST00000600729.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.79

Publications

38 publications found
Variant links:
Genes affected
MIA-RAB4B (HGNC:48352): (MIA-RAB4B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring MIA (melanoma inhibitory activity) and RAB4B (RAB4B, member RAS oncogene family) genes on chromosome 19. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is therefore unlikely to produce a protein product. [provided by RefSeq, Feb 2011]
MIA (HGNC:7076): (MIA SH3 domain containing) Predicted to enable growth factor activity. Predicted to be involved in extracellular matrix organization. Predicted to act upstream of or within cell-matrix adhesion. Predicted to be located in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000600729.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.19).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.161 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000600729.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MIA
NM_001202553.2
c.-107G>A
upstream_gene
N/ANP_001189482.1Q16674-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MIA-RAB4B
ENST00000600729.2
TSL:5
n.-6-426G>A
intron
N/AENSP00000472384.1W4VSR3
MIA
ENST00000928258.1
c.-6-426G>A
intron
N/AENSP00000598317.1
MIA
ENST00000597600.5
TSL:4
c.-6-426G>A
intron
N/AENSP00000472982.1M0R343

Frequencies

GnomAD3 genomes
AF:
0.120
AC:
18223
AN:
152020
Hom.:
1248
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0703
Gnomad AMI
AF:
0.0330
Gnomad AMR
AF:
0.135
Gnomad ASJ
AF:
0.117
Gnomad EAS
AF:
0.0782
Gnomad SAS
AF:
0.169
Gnomad FIN
AF:
0.139
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.145
Gnomad OTH
AF:
0.115
GnomAD4 exome
AF:
0.123
AC:
2547
AN:
20724
Hom.:
193
AF XY:
0.126
AC XY:
1350
AN XY:
10692
show subpopulations
African (AFR)
AF:
0.0488
AC:
20
AN:
410
American (AMR)
AF:
0.143
AC:
395
AN:
2756
Ashkenazi Jewish (ASJ)
AF:
0.0814
AC:
28
AN:
344
East Asian (EAS)
AF:
0.0630
AC:
81
AN:
1286
South Asian (SAS)
AF:
0.147
AC:
347
AN:
2356
European-Finnish (FIN)
AF:
0.108
AC:
60
AN:
558
Middle Eastern (MID)
AF:
0.0435
AC:
2
AN:
46
European-Non Finnish (NFE)
AF:
0.125
AC:
1488
AN:
11908
Other (OTH)
AF:
0.119
AC:
126
AN:
1060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
107
214
320
427
534
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.120
AC:
18247
AN:
152140
Hom.:
1252
Cov.:
32
AF XY:
0.121
AC XY:
8992
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.0703
AC:
2920
AN:
41526
American (AMR)
AF:
0.136
AC:
2070
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
407
AN:
3472
East Asian (EAS)
AF:
0.0779
AC:
403
AN:
5170
South Asian (SAS)
AF:
0.170
AC:
820
AN:
4816
European-Finnish (FIN)
AF:
0.139
AC:
1469
AN:
10588
Middle Eastern (MID)
AF:
0.122
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
0.145
AC:
9853
AN:
67972
Other (OTH)
AF:
0.113
AC:
239
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
801
1603
2404
3206
4007
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
212
424
636
848
1060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.134
Hom.:
6281
Bravo
AF:
0.114
Asia WGS
AF:
0.119
AC:
415
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.19
CADD
Benign
20
DANN
Benign
0.76
PhyloP100
1.8
PromoterAI
0.023
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2233152;
hg19: chr19-41281016;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.